Shenlingcao Oral Liquid for Patients With Stage II or IIIA NSCLC

Clinical trial NCT03712969 · COMPLETED

Trial details

NCT number: NCT03712969
Sponsor: West China Hospital
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Carcinoma, Non-Small-Cell Lung Chemotherapy, Adjuvant

Start date: 2018-11-05
Primary completion: 2022-03-14
Enrollment: 527

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.